Improving the quality of anticoagulant therapy in patients with mechanical heart valves: What are we waiting for?

European Heart Journal

Volumn 28, Issue 20, 2007, Pages 2424-2426

  Herijgers, Paul ^a   Verhamme, Peter ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; COUMARIN ANTICOAGULANT; CYTOCHROME P450 2C9; THROMBIN INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; BLEEDING; CLINICAL TRIAL; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; EDITORIAL; GENOTYPE; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MITRAL VALVE; PRIORITY JOURNAL; SELF CARE; SELF MONITORING; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; AORTIC VALVE; COUMARINS; HEART VALVE PROSTHESIS; HUMANS; INTERNATIONAL NORMALIZED RATIO; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; THROMBOEMBOLISM;

EID: 35349012236     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm405     Document Type: Editorial

References (15)

1. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641.
2. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:73-154.
3. Butchart EG, Gohlke-Bärwolf C, Antunes MJ, Tornos P, De caterina R, Cormier B, Prendergast B, Iung B, Bjornstad H, Leport C, Hall RJC, Vahanian A. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463-2471.
4. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 2006;114:84-231.
5. Bodnar E. The Medtronic Parallel (TM) valve and the lessons learned. J Heart Valve Dis 1996;5:572-573.
6. Van Nooten GJ, Van Belleghem Y, Caes F, François K, Van Overbeke H, Bové T, Taeymans Y. Lower-intensity anticoagulation for mechanical heart valves: a new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003;12:495-502.
7. Williams MA, van Riet S. The On-X heart valve: mid-term results in a poorly anticoagulated population. J Heart Valve Dis 2006;15:80-86.
8. Caldwell MD, Berg RL, Zhang KQ, Glurich I, Schmelzer JR, Yale SH, Vidaeillet H, Burmester J. Evaluation of genetic factors for warfarin dose prediction. Clin Med Res 2007;5:8-16.
9. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204S-233S.
10. Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous. Ann Thorac Surg 2001;72:44-48.
11. Koertke H, Zitterman A, Wagner O, Koerfer R. Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg 2007;83:24-29.
12. Koertke H, Zittermann A, Tenderich G, Wagner O, El-Arousy M, Krian A, Ennker J, Taborski U, Klövekorn WP, Moosdorf R, Saggau W, Koerfer R. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. Eur Heart J 2007;28:2479-2484. First published on September 21, 2007, doi:10.1093/eurheartj/ehm391.
13. Koertke H, Minami K, Boethig D, Breymann T, Seifert D, Wagner O, Atmacha N, Krian A, Taborski U, Klövekorn WP, Moosdorf R, Saggau W, Koerfer R. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003;108(Suppl II):II75-II78.
14. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003;349:631-639.
15. Eikelboom JW, Weitz JI. A replacement for warfarin. The search continues. Circulation 2007;116:131-133.